共 404 条
- [1] Van der Zee RP(2013)The increasing incidence of anal cancer: can it be explained by trends in risk groups? Neth J Med 71 401-411
- [2] Richel O(2017)Worldwide burden of cancer attributable to HPV by site, country and HPV type Int J Cancer 141 664-670
- [3] de Vries HJC(2004)Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer Cancer 101 270-280
- [4] Prins JM(1997)Sexually transmitted infection as a cause of anal cancer N Engl J Med 337 1350-1358
- [5] de Martel C(2004)HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome? J Acquir Immune Defic Syndr 37 1563-1565
- [6] Plummer M(2007)Risk of anogenital cancer after diagnosis of cervical intraepithelial neoplasia: a prospective population-based study Lancet Oncol 8 311-316
- [7] Vignat J(2015)An update on anal neoplasia Histopathology 66 147-160
- [8] Franceschi S(1996)Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin Lancet 348 1049-1054
- [9] Daling JR(1996)Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study J Clin Oncol 14 2527-2539
- [10] Madeleine MM(1997)Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups J Clin Oncol 15 2040-2049